Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,216 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dupilumab but not cyclosporine treatment shifts the microbiome toward a healthy skin flora in patients with moderate-to-severe atopic dermatitis.
Hartmann J, Moitinho-Silva L, Sander N, Harder I, Häsler R, Rodriguez E, Haufe E, Kleinheinz A, Abraham S, Heratizadeh A, Weisshaar E, Schäkel K, Handrick C, Augustin M, Wollenberg A, Staubach-Renz P, Ertner K, Sticherling M, Schwarz B, Quist S, Wiemers F, Schenck F, Wildberger J, Tittmann L, Lieb W, Schmitt J, Werfel T, Weidinger S; TREATgermany Study Group. Hartmann J, et al. Among authors: schmitt j. Allergy. 2023 Aug;78(8):2290-2300. doi: 10.1111/all.15742. Epub 2023 Apr 18. Allergy. 2023. PMID: 37032440
Itching and treatments in atopic dermatitis (AD): results from the German AD registry TREATgermany.
Weisshaar E, Bentz P, Haufe E, Heinrich L, Apfelbacher C, Heratizadeh A, Abraham S, Harder I, Kleinheinz A, Wollenberg A, Schäkel K, Wiemers F, Ertner K, Augustin M, Wildberger J, von Kiedrowski R, Worm M, Zink A, Effendy I, Asmussen A, Pawlak M, Sticherling M, Hilgers M, Handrick C, Quist S, Schwarz B, Bell M, Staubach-Renz P, Hong-Weldemann SH, Homey B, Bruecher J, Weidinger S, Werfel T, Schmitt J; TREATgermany study group. Weisshaar E, et al. Among authors: schmitt j. Br J Dermatol. 2023 Feb 22;188(3):430-432. doi: 10.1093/bjd/ljac070. Br J Dermatol. 2023. PMID: 36763757 No abstract available.
Large cohort study shows increased risk of developing atopic dermatitis after COVID-19 disease.
Schmitt J, Ehm F, Vivirito A, Wende D, Batram M, Loser F, Menzer S, Ludwig M, Roessler M, Seifert M, König C, Schulte C, Buschmann T, Hertle D, Ballesteros P, Baßler S, Bertele B, Bitterer T, Riederer C, Sobik F, Kind B, Abraham S, Tesch F. Schmitt J, et al. Allergy. 2024 Jan;79(1):232-234. doi: 10.1111/all.15827. Epub 2023 Jul 20. Allergy. 2024. PMID: 37469301 No abstract available.
Comment on: "Interim results from the PEDISTAD Real-World Registry by Paller et al"-First results from the German TREATkids registry for children and adolescents with moderate-to-severe atopic dermatitis.
Ott H, Abraham S, Kind B, Haufe E, Weidinger S, Werfel T, Schmitt J; TREATgermany Study Group. Ott H, et al. Among authors: schmitt j. J Am Acad Dermatol. 2024 Jan;90(1):e31-e33. doi: 10.1016/j.jaad.2023.08.092. Epub 2023 Sep 17. J Am Acad Dermatol. 2024. PMID: 37717725 No abstract available.
S3 guideline Atopic dermatitis: Part 2 - Systemic treatment.
Werfel T, Heratizadeh A, Aberer W, Augustin M, Biedermann T, Bauer A, Fölster-Holst R, Kahle J, Kinberger M, Nemat K, Neustädter I, Peters E, von Kiedrowski R, Schmid-Grendelmeier P, Schmitt J, Schwennesen T, Simon D, Spindler T, Traidl-Hoffmann C, Werner RN, Wollenberg A, Worm M, Ott H. Werfel T, et al. Among authors: schmitt j. J Dtsch Dermatol Ges. 2024 Feb;22(2):307-320. doi: 10.1111/ddg.15229. Epub 2023 Dec 31. J Dtsch Dermatol Ges. 2024. PMID: 38161245 Free article.
S3 Guideline Atopic dermatitis: Part 1 - General aspects, topical and non-drug therapies, special patient groups.
Werfel T, Heratizadeh A, Aberer W, Augustin M, Biedermann T, Bauer A, Fölster-Holst R, Kahle J, Kinberger M, Nemat K, Neustädter I, Peters E, von Kiedrowski R, Schmid-Grendelmeier P, Schmitt J, Schwennesen T, Simon D, Spindler T, Traidl-Hoffmann C, Werner RN, Wollenberg A, Worm M, Ott H. Werfel T, et al. Among authors: schmitt j. J Dtsch Dermatol Ges. 2024 Jan;22(1):137-153. doi: 10.1111/ddg.15230. Epub 2024 Jan 3. J Dtsch Dermatol Ges. 2024. PMID: 38171719 Free article.
[No title available]
[No authors listed] [No authors listed] PMID: 38212907
S3-Leitlinie Atopische Dermatitis: Teil 2 - Systemische Therapie: S3 guideline Atopic dermatitis: Part 2 - Systemic treatment.
Werfel T, Heratizadeh A, Aberer W, Augustin M, Biedermann T, Bauer A, Fölster-Holst R, Kahle J, Kinberger M, Nemat K, Neustädter I, Peters E, von Kiedrowski R, Schmid-Grendelmeier P, Schmitt J, Schwennesen T, Simon D, Spindler T, Traidl-Hoffmann C, Werner RN, Wollenberg A, Worm M, Ott H. Werfel T, et al. Among authors: schmitt j. J Dtsch Dermatol Ges. 2024 Feb;22(2):307-322. doi: 10.1111/ddg.15229_g. J Dtsch Dermatol Ges. 2024. PMID: 38361206 Free article.
Stratum corneum and microbial biomarkers precede and characterize childhood atopic dermatitis.
Fonfara M, Hartmann J, Stölzl D, Sander N, Harder I, Rodriguez E, Hübenthal M, Mazur C, Kerzel S, Kabesch M, Schmitt J, Emmert H, Suhrkamp I, Weidinger S. Fonfara M, et al. Among authors: schmitt j. J Eur Acad Dermatol Venereol. 2024 Feb 29. doi: 10.1111/jdv.19932. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 38421042
Treatment of moderate-to-severe atopic dermatitis with baricitinib: Results from an interim analysis of the TREATgermany registry.
Traidl S, Heinrich L, Siegels D, Heratizadeh A, Kind B, Haufe E, Abraham S, Schäfer T, Augustin M, Harder I, Pinter A, Schäkel K, Wollenberg A, Ertner K, Ramaker-Brunke J, Bong A, Quist S, Gorriahn-Maiterth H, Schenck F, Sticherling M, Effendy I, Schwarz B, Handrick C, Asmussen A, Weidinger S, Schmitt J, Werfel T; TREATgermany study group. Traidl S, et al. Among authors: schmitt j. J Eur Acad Dermatol Venereol. 2024 Mar 28. doi: 10.1111/jdv.19979. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 38545850 No abstract available.
2,216 results